Northern Trust’s Oragenics OGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-101
Closed -$19.1K 4616
2022
Q4
$19.1K Hold
101
﹤0.01% 4497
2022
Q3
$41K Hold
101
﹤0.01% 4380
2022
Q2
$63K Hold
101
﹤0.01% 4339
2022
Q1
$62K Hold
101
﹤0.01% 4485
2021
Q4
$81K Hold
101
﹤0.01% 4481
2021
Q3
$115K Hold
101
﹤0.01% 4365
2021
Q2
$128K Hold
101
﹤0.01% 4298
2021
Q1
$165K Buy
101
+68
+206% +$123K ﹤0.01% 4163
2020
Q4
$27K Buy
33
+10
+43% +$8.8K ﹤0.01% 4302
2020
Q3
$24K Hold
23
﹤0.01% 4191
2020
Q2
$29K Sell
23
-2
-8% -$1.97K ﹤0.01% 4121
2020
Q1
$26K Hold
25
﹤0.01% 4055
2019
Q4
$23K Hold
25
﹤0.01% 4145
2019
Q3
$24K Buy
25
+18
+257% +$15K ﹤0.01% 4142
2019
Q2
$6K Hold
7
﹤0.01% 4232
2019
Q1
$8K Buy
+7
New +$11K ﹤0.01% 4182
2018
Q1
Sell
-2
Closed -$7K 4272
2017
Q4
$7K Hold
2
﹤0.01% 4204
2017
Q3
$13K Hold
2
﹤0.01% 4185
2017
Q2
$11K Hold
2
﹤0.01% 4214
2017
Q1
$14K Buy
2
+1
+100% +$10.8K ﹤0.01% 4179
2016
Q4
$13K Hold
1
﹤0.01% 4126
2016
Q3
$11K Hold
1
﹤0.01% 4130
2016
Q2
$12K Hold
1
﹤0.01% 4155
2016
Q1
$21K Hold
1
﹤0.01% 4129
2015
Q4
$35K Hold
1
﹤0.01% 4109
2015
Q3
$39K Buy
+1
New +$40.7K ﹤0.01% 4119

Other funds holding OGEN

Northern Trust's OGEN Position: Q1 2023 in Review

Northern Trust sold out of Oragenics (OGEN) in Q1 2023, closing a stake of 101 shares — an estimated $19.1K sold.

Northern Trust first reported a position in OGEN in Q3 2015 and held it in 26 quarters. The position peaked at $165K in Q1 2021. 10 funds tracked by Wall St. Rank hold OGEN as of Q1 2023.

  • Northern Trust reported no remaining Oragenics position as of Q1 2023 after selling out during the quarter.
  • Northern Trust sold 101 Oragenics shares in Q1 2023, an estimated $19.1K.
  • Northern Trust first reported a position in Oragenics in Q3 2015 and held it in 26 quarters.
  • Northern Trust's Oragenics position peaked at $165K in Q1 2021.
  • 10 funds tracked by Wall St. Rank held Oragenics as of Q1 2023.

Based on Northern Trust's 13F filing for Q1 2023, filed 15 May 2023.